Granting additional market exclusivity to the drug Ansaid : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 20, 1992
Saved in:
| Corporate Author: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Washington :
U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,
1992
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000cam a2200000Ia 4500 | ||
|---|---|---|---|
| 001 | 26019075 | ||
| 003 | OCoLC | ||
| 005 | 19920824135743.0 | ||
| 008 | 920615s1992 dcu b f000 0 eng d | ||
| 020 | |a 0160383773 | ||
| 040 | |a FTC |c FTC |d GPO | ||
| 043 | |a n-us--- | ||
| 049 | |a VLAG | ||
| 086 | 0 | |a GOVDOCS Y 4.En 2/3:102-99 | |
| 110 | 1 | |a United States. |b Congress. |b House. |b Committee on Energy and Commerce. |b Subcommittee on Health and the Environment | |
| 245 | 1 | 0 | |a Granting additional market exclusivity to the drug Ansaid : |b hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 20, 1992 |
| 260 | |a Washington : |b U.S. G.P.O. : |b For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, |c 1992 | ||
| 300 | |a iii, 66 p. ; |c 24 cm | ||
| 500 | |a "Serial no. 102-99." | ||
| 610 | 2 | 0 | |a Upjohn Company |
| 650 | 0 | |a Flurbiprofen |x Law and legislation |z United States | |
| 650 | 0 | |a Pharmaceutical policy |z United States | |
| 650 | 0 | |a Patent extensions |z United States | |
| 907 | |a .b1390764 | ||
| 998 | |a docs | ||
| 999 | |c 31348 | ||
| 852 | |a Law Library |b Government Documents |h GOVDOCS Y 4.En 2/3:102-99 |p 33940004365282 | ||